PT - JOURNAL ARTICLE AU - Liu, Pengbo AU - Sablon, Orlando III AU - Wang, Yuke AU - Hilton, Stephen Patrick AU - Khalil, Lana AU - Ingersoll, Jessica Mae AU - Truell, Jennifer AU - Edupuganti, Sri AU - Alaaeddine, Ghina AU - Naji, Amal AU - Monarrez, Eduardo AU - Wolfe, Marlene AU - Rouphael, Nadine AU - Kraft, Colleen AU - Moe, Christine L. TI - Longitudinal Fecal Shedding of SARS-CoV-2, Pepper Mild Mottle Virus, and Human Mitochondrial DNA in COVID-19 Patients AID - 10.1101/2024.04.22.24305845 DP - 2024 Jan 01 TA - medRxiv PG - 2024.04.22.24305845 4099 - http://medrxiv.org/content/early/2024/04/22/2024.04.22.24305845.short 4100 - http://medrxiv.org/content/early/2024/04/22/2024.04.22.24305845.full AB - Since the coronavirus disease 2019 (COVID-19) pandemic, wastewater-based epidemiology (WBE) has been widely applied in many countries and regions for monitoring COVID-19 transmission in the population through testing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in wastewater. However, the lack of dynamic level of viral shedding in the wastewater and accurate number of infections in the community creates challenges in predicting COVID-19 prevalence in the population and interpreting WBE results. In this study, we measured SARS-CoV-2, pepper mild mottle virus (PMMoV), and human mitochondrial DNA (mtDNA) in longitudinal fecal samples collected from 42 COVID-19 patients for up to 42 days after diagnosis. SARS-CoV-2 RNA was detected in 73.1% (19/26) of inpatient study participants in at least one of the collected fecal specimens during the sampling period. Most participants shed the virus within three weeks after diagnosis, but five inpatient participants still shed the virus between 20 and 60 days after diagnosis. The median concentration of SARS-CoV-2 in positive fecal samples was 1.08×105 genome copies (GC)/gram dry fecal material. PMMoV and mtDNA were detected in 99.4% (154/155) and 100% (155/155) of all fecal samples, respectively. The median concentrations of PMMoV RNA and mtDNA in fecal samples were 1.73×107 and 2.49×108 GC/dry gram, respectively. These results provide important information about the dynamics of fecal shedding of SARS-CoV-2 and two human fecal indicators in COVID-19 patients. mtDNA showed higher positive rates, higher concentrations, and less variability between and within individuals than PMMoV, suggesting that mtDNA could be a better normalization factor for WBE results than PMMoV.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the NIH Rapid Acceleration of Diagnostics (RADx) initiative (contract No. 75N92021C00012 to Ceres Nanosciences, Inc) through a contract from Ceres Nanosciences to Emory University.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ethical approval was granted by Emory University Institutional Review Board (IRB00022371) for this studyI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors